A citation-based method for searching scientific literature

B Wang, J Zhong, H Lin, Z Zhao, Z Yan, H He, Y Ni, D Liu, Z Zhu. Diabetes Obes Metab 2013
Times Cited: 129



Julio Rosenstock, Denis Raccah, László Korányi, Laura Maffei, Gabor Boka, Patrick Miossec, John E Gerich. Diabetes Care 2013
Times Cited: 166




List of shared articles



Times cited

An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning.
Maryam Rameshrad, Bibi Marjan Razavi, Jean-Daniel Lalau, Marc E De Broe, Hossein Hosseinzadeh. Iran J Basic Med Sci 2020
2

Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force.
Sanjay Kalra, Ashok Kumar Das, Rakesh Kumar Sahay, Manash Pratim Baruah, Mangesh Tiwaskar, Sambit Das, Sudip Chatterjee, Banshi Saboo, Ganapathi Bantwal, Saptarshi Bhattacharya,[...]. Diabetes Ther 2019
9

Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes.
Gül Bahtiyar, Jean Pujals-Kury, Alan Sacerdote. Curr Diab Rep 2018
15

PRISMA-efficacy and safety of lixisenatide for type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
Zhen-Gang Wei, Man-Cai Wang, Hui-Han Zhang, Zhe-Yuan Wang, Gen-Nian Wang, Feng-Xian Wei, Ya-Wu Zhang, Xiao-Dong Xu, You-Cheng Zhang. Medicine (Baltimore) 2018
0


Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists.
Yu Mi Kang, Chang Hee Jung. Endocrinol Metab (Seoul) 2016
25


Cardiometabolic Effects of a New Class of Antidiabetic Agents.
Cyrus V Desouza, Namita Gupta, Anery Patel. Clin Ther 2015
28

Incretin-based therapies for obesity treatment.
Aline Haas de Mello, Morgana Prá, Larissa Colonetti Cardoso, Rosiane de Bona Schraiber, Gislaine Tezza Rezin. Metabolism 2015
19